CDT Equity Inc. (CDT) vs Clearside Biomedical, Inc. (CLSDQ)

CDT Equity Inc. and Clearside Biomedical, Inc. are both Biotechnology companies. CDT Equity Inc. is the larger, with a market value of $2.4M against $2.2M — 1.1× the size. CDT Equity Inc. has the higher net margin (0.00% vs −780.9%) and the lower return on invested capital (−21.3% vs 0.00%). Across the 11 metrics below, CDT Equity Inc. leads on 7 and Clearside Biomedical, Inc. on 4.

Valuation

Metric CDT CLSDQ Biotechnology median
P/E n/m n/m 7.88
P/S n/m 0.39 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 10.91 10.73
Earnings yield 167,728,033.38% (2,075.24%) (28.84%)
Free cash flow yield (278,822.70%) (1,661.90%) (23.03%)

Profitability

Metric CDT CLSDQ Biotechnology median
Gross margin — 92.55% 65.16%
Operating margin 0.00% (689.76%) 0.00%
Net margin 0.00% (780.93%) 0.00%
Free cash flow margin 0.00% (653.23%) 0.00%
Return on equity (69.68%) 58.59% (57.72%)
Return on assets (55.16%) (127.43%) (49.22%)
Return on invested capital (21.28%) 0.00% 0.00%

Growth

Metric CDT CLSDQ Biotechnology median
Revenue growth (TTM) — (56.78%) 5.64%
EPS growth (last fiscal year) 98.09% 11.32% —
Revenue growth, 5-year CAGR — (5.20%) 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CDT CLSDQ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.13 2.98 4.73
Net debt to EBITDA 0.05 0.69 0.96

Dividend

Metric CDT CLSDQ Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CDT CLSDQ Biotechnology median
Market cap 2.41m 2.15m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack